NCT01977378View on ClinicalTrials.gov

A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

September 30, 2014

Conditions
Major Depressive Disorder
Interventions
DRUG

Sustained-Release Desvenlafaxine Hydrochloride

DRUG

Sustained-Release Venlafaxine Hydrochloride

Trial Locations (6)

100088

RECRUITING

Beijing An Ding Hospital, Beijing

100096

RECRUITING

Beijing HuiLongGuan Hospital, Beijing

200030

RECRUITING

The Shanghai Mental Health, Shanghai

Unknown

RECRUITING

Guangdong General Hospital, Guangzhou

RECRUITING

The Second Xiangya Hospital of Central South University, Changsha

RECRUITING

West China Hospital, Chengdu

Sponsors
All Listed Sponsors
lead

Jiangsu Hansoh Pharmaceutical Co., Ltd.

INDUSTRY

NCT01977378 - A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder | Biotech Hunter | Biotech Hunter